Gray Kueberuwa
About Gray Kueberuwa
Gray Kueberuwa serves as the Director of Molecular Immunology Research at Instil Bio in Manchester, United Kingdom, a position he has held since 2018. He holds a PhD in Oncology and an MBioch in Biochemistry from the University of Oxford.
Work at Instil Bio
Gray Kueberuwa has served as the Director of Molecular Immunology Research at Instil Bio since 2018. In this role, he focuses on advancing the understanding and application of molecular immunology within the context of cancer therapies. His work contributes to the company's mission of developing innovative treatments that harness the immune system to fight cancer. He is based in Manchester, United Kingdom, where he leads research initiatives and collaborates with other professionals in the field.
Education and Expertise
Gray Kueberuwa holds a Master of Biochemistry (MBioch) from the University of Oxford, where he studied from 2004 to 2008. He further pursued his education at the same institution, earning a PhD in Oncology from 2008 to 2012. His academic background provides a strong foundation in biochemistry and oncology, equipping him with the expertise necessary for his current research in molecular immunology.
Background
Before joining Instil Bio, Gray Kueberuwa worked at several prestigious institutions. He was a Postdoctoral Researcher at Cancer Research UK Manchester Institute from 2017 to 2018. Prior to that, he served as a Postdoctoral Research Associate at The University of Manchester from 2014 to 2017. His earlier experience includes a position as a Medicinal Virologist in the Department of Oncology at the University of Oxford from 2012 to 2014.
Professional Experience
Gray Kueberuwa has accumulated significant experience in cancer research through various roles. His tenure at Cancer Research UK Manchester Institute involved conducting advanced research projects aimed at understanding cancer mechanisms. At The University of Manchester, he contributed to ongoing research initiatives as a Postdoctoral Research Associate. His role at the University of Oxford as a Medicinal Virologist further solidified his expertise in oncology and virology.